China-based diagnostic imaging services provider Deepwise has received $17.3m in a series A+ round that included Kinzon Capital, the venture capital firm formed by diversified conglomerate Fosun, DealStreetAsia has reported.
Venture capital fund Danhua Capital led the round, which also featured investment platform FengHe Group, Dalton Venture, Tendence Capital and Beijing Dongfang Hongdao Asset Management.
Deepwise provides an image-based diagnostics imaging system in order to detect conditions such as breast and prostate cancer, as well as a chest radiograph.
The latest round follows Deepwise raising RMB35m ($5.3m at current exchange rates) in series A funding from undisclosed investors in 2016, according to DealStreetAsia.